Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes

Radiomics-based non-invasive biomarkers are promising to facilitate the translation of therapeutically related molecular subtypes for treatment allocation of patients with head and neck squamous cell carcinoma (HNSCC).